| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ME | 23andMe Holding Co. | Hillan Kenneth J. | Chief Therapeutics Officer | Jun 05, 2023 | Option Exercise | $2.08 | 15,347 | 31,922 | 221,876 | Jun 07, 2023, 04:20 PM | |
| ME | 23andMe Holding Co. | Hillan Kenneth J. | Chief Therapeutics Officer | May 20, 2023 | Option Exercise | $1.94 | 4,628 | 8,978 | 192,842 | May 23, 2023, 04:05 PM | |
| ME | 23andMe Holding Co. | Hillan Kenneth J. | Chief Therapeutics Officer | Feb 20, 2023 | Option Exercise | $2.87 | 5,457 | 15,662 | 191,705 | Feb 22, 2023, 05:12 PM | |
| ME | 23andMe Holding Co. | Hillan Kenneth J. | Chief Therapeutics Officer | Nov 20, 2022 | Option Exercise | $2.99 | 4,628 | 13,838 | 197,162 | Nov 22, 2022, 04:11 PM | |
| ME | 23andMe Holding Co. | Hillan Kenneth J. | Chief Therapeutics Officer | Aug 24, 2022 | Sale | $3.64 | 8,753 | 31,861 | 196,083 | Aug 25, 2022, 05:00 PM | |
| ME | 23andMe Holding Co. | Hillan Kenneth J. | Chief Therapeutics Officer | Aug 20, 2022 | Option Exercise | $3.33 | 4,628 | 15,411 | 204,836 | Aug 22, 2022, 06:12 PM | |
| ME | 23andMe Holding Co. | Hillan Kenneth J. | Chief Therapeutics Officer | Jun 01, 2022 | Option Exercise | $2.82 | 4,627 | 13,048 | 209,464 | Jun 02, 2022, 04:26 PM | |
| AKAO | Achaogen Inc | Hillan Kenneth J. | See Remarks | Jun 28, 2018 | Option Exercise | $6.10 | 177,935 | 1,084,807 | 293,336 | Jun 29, 2018, 08:33 PM | |
| AKAO | Achaogen Inc | Hillan Kenneth J. | See Remarks | Jun 26, 2018 | Sale | $9.59 | 744 | 7,135 | 115,401 | Jun 28, 2018, 04:19 PM | |
| AKAO | Achaogen Inc | Hillan Kenneth J. | See Remarks | Mar 13, 2018 | Sale | $11.74 | 2,735 | 32,109 | 95,151 | Mar 15, 2018, 07:17 PM | |
| AKAO | Achaogen Inc | Hillan Kenneth J. | See Remarks | Feb 21, 2018 | Sale | $10.67 | 4,606 | 49,146 | 97,886 | Feb 23, 2018, 08:37 PM | |
| AKAO | Achaogen Inc | Hillan Kenneth J. | Chief Executive Officer | Mar 14, 2017 | Sale | $26.58 | 3,079 | 81,840 | 98,422 | Mar 16, 2017, 07:45 PM | |
| AKAO | Achaogen Inc | Hillan Kenneth J. | Chief Executive Officer | Feb 21, 2017 | Sale | $22.76 | 1,696 | 38,601 | 61,501 | Feb 23, 2017, 07:39 PM | |
| AKAO | Achaogen Inc | Hillan Kenneth J. | Chief Executive Officer | Jan 26, 2017 | Sale | $16.78 | 1,431 | 24,012 | 63,197 | Jan 30, 2017, 09:35 PM | |
| RLYP | Relypsa Inc | Hillan Kenneth J. | Director | Sep 01, 2016 | Option Exercise | $32.00 | 3,487 | 111,584 | 2,250 | Sep 02, 2016, 12:35 PM | |
| RLYP | Relypsa Inc | Hillan Kenneth J. | Director | Jun 07, 2016 | Sale | $19.31 | 1,013 | 19,563 | 1,237 | Jun 08, 2016, 05:21 PM | |
| AKAO | Achaogen Inc | Hillan Kenneth J. | Chief Executive Officer | Mar 17, 2016 | Sale | $3.22 | 3,572 | 11,502 | 61,628 | Mar 21, 2016, 06:33 PM |
Menu